Literature DB >> 15990445

Amyotrophic lateral sclerosis mortality in the United States, 1979-2001.

James J Sejvar1, Robert C Holman, Joseph S Bresee, Kenneth D Kochanek, Lawrence B Schonberger.   

Abstract

The etiology of nonfamilial amyotrophic lateral sclerosis (ALS) remains unknown. Earlier studies have suggested an increase in the incidence of ALS over time. We performed a retrospective analysis of ALS-associated death rates and trends in the United States for 1979-2001 using death records from the national multiple cause-of-death database. The US average annual age-adjusted ALS death rate was 1.84 per 100,000 persons for 1979 through 1998. Most deaths were among adults > or =65 years of age and the median age at death was 67 years. A small overall increase in the death rate was observed primarily between 1979 and 1983, with a subsequent plateau. This slight change in the overall rate reflected apparent increases in the rates among those persons > or =65 years of age, particularly women, and persons in the 20- to 49-year-old age group. The ALS-associated death rate appeared to differ by geographic area, with a higher occurrence among most northern states. Our findings suggest that the epidemiology of ALS-associated deaths in the United States demonstrated small increases in the overall age-adjusted death rate and in the death rates among elderly women and adults 20-49 years of age. Subpopulations at higher risk for ALS were males, whites, persons > or =65 years of age, and residents of northern states. This study provides information for further studies to examine the epidemiology and risk factors associated with ALS. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15990445     DOI: 10.1159/000086679

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  31 in total

1.  The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.

Authors:  Frank O Johnson; William D Atchison
Journal:  Neurotoxicology       Date:  2009-07-24       Impact factor: 4.294

Review 2.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

3.  Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Authors:  Merit E Cudkowicz; Sarah Titus; Marianne Kearney; Hong Yu; Alexander Sherman; David Schoenfeld; Douglas Hayden; Amy Shui; Benjamin Brooks; Robin Conwit; Donna Felsenstein; David J Greenblatt; Myles Keroack; John T Kissel; Robert Miller; Jeffrey Rosenfeld; Jeffrey D Rothstein; Ericka Simpson; Nina Tolkoff-Rubin; Lorne Zinman; Jeremy M Shefner
Journal:  Lancet Neurol       Date:  2014-10-05       Impact factor: 44.182

4.  Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy.

Authors:  Vittorio Govoni; Edward Cesnik; Ilaria Casetta; Valeria Tugnoli; Maria Rosaria Tola; Enrico Granieri
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

5.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Authors:  Raffaella Uccelli; Alessandra Binazzi; Pierluigi Altavista; Stefano Belli; Pietro Comba; Marina Mastrantonio; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2007-09-14       Impact factor: 8.082

6.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 7.  Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Exp Gerontol       Date:  2009-07-19       Impact factor: 4.032

Review 8.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

Review 9.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.